为推动斯丹姆医药与JP医学咨询之间的深度合作,澳大利亚驻成都总领事兼澳洲贸易投资委员会负责人Helen Dai女士率政府小组访问斯丹姆上海办公室

On August 20, following the strategic partnership between the two companies a few weeks ago, Ms. Helen Dai, Consul General of Australia in Chengdu and Head of Austrade, led a government team to visit Stam’s Shanghai office. Yu Wenhao, Senior Vice President and CBO of Stam Pharmaceutical, and Bao Yuanwu, General Manager of Shanghai and…

阅读文章
斯丹姆医药与澳大利亚JP医学咨询顾问有限公司达成战略合作,加快国际化进程、为中国生物医药企业在澳临床试验保驾护航

On July 24, Stam Pharmaceuticals (Beijing) Co., Ltd. (hereinafter referred to as “Stam Pharmaceuticals”) and JP Medical Consulting Pty Ltd (hereinafter referred to as “JP Medical Consulting”) of Australia announced a strategic cooperation. The cooperation aims to make full use of the clinical resources and professional advantages of both parties in the field of medicine…

阅读文章
国际顶级专家Mark von ltzstein院士、庞建宏教授受邀到访重庆医科大学附属第二医院妇产科开展学术交流

In order to strengthen academic exchanges and cooperation with top international medical teams and promote high-quality development of disciplines, the Department of Obstetrics and Gynecology of the Second Affiliated Hospital of Chongqing Medical University invited Professor Mark von ltzstein, a fellow of the Royal Australian Institute of Chemistry, a fellow of the Australian Academy of…

阅读文章
2024年中国国际药物信息大会年会暨展览会

From May 16 to 19, 2024, the Australian Trade and Investment Commission (Austrade) led a delegation of 16 leading Australian clinical trial providers to the DIA China Annual Meeting 2024, showcasing Australia’s strengths and services in drug development, technological innovation, and clinical trials. As one of 16 Australian companies, JP Medical Consulting made its debut…

阅读文章
推进国际合作 - JP医学咨询

Professor Mark von Itzstein, JP Medical Consultant, Fellow of the Australian Academy of Science, and Dr. James Pang, CEO of JP Medical Consulting, have been appointed as honorary and visiting professors of Chongqing Medical University. 推进国际合作 澳大利亚皇家化学研究所院士受聘重庆医科大学荣誉教授 大咖来了!国际顶级学者受聘重医荣誉教授

阅读文章